GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sun-Novo Pharmaceutical Research Co Ltd (SHSE:688621) » Definitions » Price-to-Operating-Cash-Flow

Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Price-to-Operating-Cash-Flow : 29.55 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Sun-Novo Pharmaceutical Research Co Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Beijing Sun-Novo Pharmaceutical Research Co's share price is ¥48.08. Beijing Sun-Novo Pharmaceutical Research Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.63. Hence, Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow Ratio for today is 29.55.

The historical rank and industry rank for Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:688621' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 29.72   Med: 89.93   Max: 499.55
Current: 29.72

During the past 7 years, Beijing Sun-Novo Pharmaceutical Research Co's highest Price-to-Operating-Cash-Flow Ratio was 499.55. The lowest was 29.72. And the median was 89.93.

SHSE:688621's Price-to-Operating-Cash-Flow is ranked worse than
72.43% of 682 companies
in the Drug Manufacturers industry
Industry Median: 16.105 vs SHSE:688621: 29.72

Beijing Sun-Novo Pharmaceutical Research Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.63.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Beijing Sun-Novo Pharmaceutical Research Co was 916.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.00% per year.

During the past 7 years, Beijing Sun-Novo Pharmaceutical Research Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 105.10% per year. The lowest was 3.30% per year. And the median was 15.15% per year.


Beijing Sun-Novo Pharmaceutical Research Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Sun-Novo Pharmaceutical Research Co Price-to-Operating-Cash-Flow Chart

Beijing Sun-Novo Pharmaceutical Research Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - 96.40 78.65 84.14

Beijing Sun-Novo Pharmaceutical Research Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 499.55 273.58 57.97 84.14 38.24

Competitive Comparison of Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow falls into.



Beijing Sun-Novo Pharmaceutical Research Co Price-to-Operating-Cash-Flow Calculation

Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=48.08/1.627
=29.55

Beijing Sun-Novo Pharmaceutical Research Co's Share Price of today is ¥48.08.
Beijing Sun-Novo Pharmaceutical Research Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.63.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Beijing Sun-Novo Pharmaceutical Research Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Beijing Sun-Novo Pharmaceutical Research Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Business Description

Traded in Other Exchanges
N/A
Address
No. 79 Shuangying West Road, 1st Floor, Building 7, Science Park, Changping District, Beijing, CHN, 102200
Beijing Sun-Novo Pharmaceutical Research Co Ltd is engaged in providing professional research and development outsourcing services for pharmaceutical companies.
Executives
Shao Yan Director
Zhao Ling Yang Director
Liu Yu Jing Directors, senior managers
Li Qian Director

Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Headlines

No Headlines